-
Taxonomy & unit
-
ratio: %
-
Description
-
Return on equity can be defined as the amount of net income returned as a percentage of shareholders equity. Return on equity measures a corporation's profitability by revealing how much profit a company generates with the money shareholders have invested.
-
Summary
-
Kiniksa Pharmaceuticals International, plc quarterly/annual Return On Equity history and growth rate from 2018 to Q3 2025.
- Kiniksa Pharmaceuticals International, plc Return On Equity for the quarter ending September 30, 2025 was 7.46 %.
- Kiniksa Pharmaceuticals International, plc annual Return On Equity for 2024 was -9.92 %, a 390% decline from 2023.
- Kiniksa Pharmaceuticals International, plc annual Return On Equity for 2023 was 3.42 %, a 94.9% decline from 2022.
- Kiniksa Pharmaceuticals International, plc annual Return On Equity for 2022 was 66.7 %.
Return On Equity, Quarterly (%)
Return On Equity, YoY Quarterly Growth (%)
Return On Equity, Annual (%)
Return On Equity, YoY Annual Growth (%)